Literature DB >> 32151917

Ethanol extract of Magnoliae cortex (EEMC) limits teratoma formation of pluripotent stem cells by selective elimination of undifferentiated cells through the p53-dependent mitochondrial apoptotic pathway.

Aeyung Kim1, Seo-Young Lee2, Chang-Seob Seo2, Sun-Ku Chung3.   

Abstract

BACKGROUND: Induced pluripotent stem cells (iPSCs) are regarded as the best potential cell source for cell-based regenerative medicine. To develop a safe and efficient iPSC-based cell therapy, it is very important to avoid possible teratoma formation, which can arise from undifferentiated iPSCs (USCs) remaining among differentiated cell products. Dried bark of Magnolia officinalis (Magnolia cortex, MC) has long been used in traditional medicine to treat gastrointestinal ailments and allergic diseases, and has shown have various pharmacological activities, including anti-bacterial, anti-inflammatory, and anti-cancer effects. However, its effects on iPSCs have not yet been examined.
PURPOSE: In this study, we investigated the selective cytotoxic effects of ethanol extract of MC (EEMC) on undifferentiated iPSCs and elucidated the underlying apoptotic mechanisms in detail. We also investigated the inhibitory effects of EEMC on teratoma formation via in ovo experiments.
RESULTS: We found that EEMC greatly reduced cell growth and induced apoptotic cell death in USCs, but not in differentiated or normal cells. EEMC caused G2/M cell cycle arrest, mitochondrial damage, and caspase activation of USCs, accompanied by p53 accumulation. In p53KO human iPSCs, EEMC had no cytotoxicity, reinforcing that EEMC-mediated apoptosis of USCs is p53-dependent. EEMC did not cause DNA damage in iPSC-derived differentiated cells. In ovo teratoma formation assay revealed that EEMC treatment before injection efficiently eliminated USCs and prevented teratoma formation.
CONCLUSIONS: These results collectively indicate that EEMC has potent anti-teratoma activity, and therefore can be used for the development of safe iPSC-based therapy.
Copyright © 2020 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Apoptosis; Induced pluripotent stem cell; Magnolia cortex; Teratoma; p53

Year:  2020        PMID: 32151917     DOI: 10.1016/j.phymed.2020.153198

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  3 in total

1.  Enzymatically Forming Intranuclear Peptide Assemblies for Selectively Killing Human Induced Pluripotent Stem Cells.

Authors:  Shuang Liu; Qiuxin Zhang; Adrianna N Shy; Meihui Yi; Hongjian He; Shijiang Lu; Bing Xu
Journal:  J Am Chem Soc       Date:  2021-09-16       Impact factor: 16.383

Review 2.  Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update.

Authors:  Yiping Lin; Yuke Li; Yuanlian Zeng; Bin Tian; Xiaolan Qu; Qianghua Yuan; Ying Song
Journal:  Front Pharmacol       Date:  2021-03-17       Impact factor: 5.810

Review 3.  The potential of plant extracts in cell therapy.

Authors:  Caifeng Li; Zhao Cui; Shiwen Deng; Peng Chen; Xianyu Li; Hongjun Yang
Journal:  Stem Cell Res Ther       Date:  2022-09-14       Impact factor: 8.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.